Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 3, 2026

Spire reaffirms 5%–7% EPS growth target and $11.2B capital plan as Tennessee acquisition nears close

View original at seekingalpha.com
Spire reaffirms 5%–7% EPS growth target and $11.2B capital plan as Tennessee acquisition nears close Earnings Call Insights: Spire Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Adjusted earnings of $1.77 per share, an increase from $1.34 per share a year ago, attributing the improvement to solid execution in our Gas Utility business, supported by new rates across all of the utilities

    80% confidence
  • Focus on closing and integrating Tennessee, highlighting scale benefits for customers through shared services

    80% confidence
  • The next rate case filing in Missouri is anticipated after fiscal year-end before Thanksgiving

    80% confidence
  • The integration is a significant effort, supported by an 18-month Transition Services Agreement

    80% confidence
  • The adjusted earnings range for Corporate and Other was updated to negative $40 million to negative $46 million, lowering the midpoint by $9 million to reflect higher interest expense from redeeming preferred stock

    80% confidence
  • About $750 million remains to be raised or recycled for the Tennessee acquisition, and any equity market activity would likely occur after the next earnings call

    80% confidence
  • An announcement on the storage asset sale is expected later in the quarter

    80% confidence
  • Cost management and customer affordability remain central to Spire's strategy, with ongoing investments in system improvements and safety

    80% confidence
  • Gas Utilities earned $104 million, up $26 million year-over-year, while Gas Marketing and Midstream also contributed positively, partially offset by increased corporate costs and interest expense

    80% confidence
  • Spire remains on track to close the acquisition of the Piedmont Tennessee business in calendar Q1 2026

    80% confidence
  • Reaffirmed the company's 2026 adjusted EPS guidance of $5.25 to $5.45 and its 2027 guidance of $5.65 to $5.85, alongside a long-term 5% to 7% adjusted EPS growth target

    80% confidence
  • Despite extreme conditions, natural gas once again distinguished itself, underscoring that direct use of natural gas remains the most reliable and affordable way to heat your home

    80% confidence
  • For the first quarter, we reported adjusted earnings of $108 million or $1.77 per share compared to $81 million or $1.34 per share a year ago

    80% confidence
  • I feel very confident in our ability to do this

    80% confidence
  • The storage asset sale process has gone a little longer than we initially anticipated but emphasized continued strong interest

    80% confidence
  • There is an offsetting impact from preferred stock redemption, so net-net, EPS is unchanged

    80% confidence
  • Utilities met all customer obligations during January gas market volatility and hedging strategies performed as expected

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
Spire reaffirms 5%–7% EPS growth target and $11.2B capital plan as Tennessee acquisition nears close — Source | Via News | Via News